$25.89 $0.21 per serving
Product analysis
Huperzine A 200 mcg offers an economical, clearly labeled option for someone specifically seeking huperzine.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality40
The plant extract source is identified. Its form quality and absorption cannot be established.
Ingredient Transparency100
The amount and plant extract source are disclosed. Those details make the ingredient easier to identify and compare.
Value For Money100
The huperzine amount compares favorably on cost. That supports value for someone specifically seeking this ingredient.
Customer Satisfaction80
Customer feedback is positive across a substantial number of ratings. The feedback describes satisfaction and does not establish effectiveness.
Product Focus63
One ingredient keeps the formula focused on huperzine. Its effect on a brain signaling chemical does not establish improved memory or attention in healthy adults.
- Format
Tablet - Container
- 120 Tablet(s)
- Per serving
- $0.21
- Also available
Huperzine A 100 mcg$16.06- Customer rating
- 4.6 · 1,397 ratings
Goals
Impact
Highest effect
Huperzine · 200 mcg
Huperzine affects acetylcholine breakdown, but that mechanism and disease-treatment research do not establish routine cognitive benefit in healthy adults. The declared 200 mcg serving receives a substantial contribution in the saved comparison. That finding does not demonstrate general brain maintenance, cognitive enhancement or a suitable cycling schedule.
How this product is rated for Brain Health
Ingredient fit95
The formula contains ingredients considered relevant to brain health, with the practical contribution constrained by their amounts, identities and supported roles.
Goal fit
The ingredients considered here are concentrated on the goal, although the product is also linked to other uses.
Dose adequacy
Declared amounts contribute unevenly to the saved comparison; undisclosed amounts cannot establish an amount-based contribution.
Pathways54
The supplied findings describe mechanistic coverage. Coverage alone does not establish improvement in the corresponding cognitive abilities.
Depth
The strongest recorded area is acetylcholine signalling. This describes the supplied mechanism finding, not a demonstrated cognitive outcome.
Breadth
The recorded coverage is concentrated in one area, with limited breadth across the other brain-related mechanisms.
Evidence90
The supplied ingredient evidence has population and preparation limits; the leading saved finding should be interpreted within those limits.
Evidence strength
Huperzine leads the saved evidence comparison; its applicable population and benefit limits still govern expectations.
Studied preparation
The supplied comparison recognizes the evaluated preparations; this does not establish a matching duration or benefit for every adult.
Formulation logic100
The supplied formulation checks address partners, conflicts and amounts. They do not demonstrate added benefit from combining the ingredients.
Partner coverage
No required partner is missing among the ingredients considered in the supplied formulation check.
Conflicts
No configured ingredient conflict was identified; this is not a comprehensive safety assessment.
Effective doses
All ingredients included in this check reach its minimum amount threshold, which does not establish proven effective doses for general cognition.
Impact
Highest effect
Huperzine · 200 mcg
Huperzine inhibits the breakdown of acetylcholine, a chemical involved in cognitive signaling. The supplied clinical evidence comes from people with Alzheimer disease and does not establish routine memory or attention improvement in healthy adults. The saved findings recognize the declared amount and this mechanism, but those findings do not make treatment-cohort results applicable to general supplement use.
How this product is rated for Cognitive Support
Ingredient fit95
The formula’s relevance depends on both its ingredient focus and the usable declared amounts. The counted amounts reach their saved comparison anchors; this does not establish a proven cognitive effect.
Goal fit
The recognized ingredients are focused on this goal, although links to other uses broaden the product’s positioning.
Dose adequacy
The counted amounts reach their saved comparison anchors; this does not establish a proven cognitive effect.
Pathways60
The strongest saved connection concerns acetylcholine signalling; mechanism coverage alone does not establish cognitive improvement. The saved findings concentrate on one mechanism, limiting breadth across the other cognitive aspects.
Depth
The strongest saved connection concerns acetylcholine signalling; mechanism coverage alone does not establish cognitive improvement.
Breadth
The saved findings concentrate on one mechanism, limiting breadth across the other cognitive aspects.
Evidence91
Huperzine leads the saved evidence finding, while its specific scientific limitations still constrain expected cognitive benefits. The counted preparations meet the saved matching criteria, which does not remove limitations in the underlying cognitive findings.
Evidence strength
Huperzine leads the saved evidence finding, while its specific scientific limitations still constrain expected cognitive benefits.
Studied preparation
The counted preparations meet the saved matching criteria, which does not remove limitations in the underlying cognitive findings.
Formulation logic100
No configured conflict was identified in the supplied facts. All counted ingredients reach the saved amount threshold; that comparison is not proof of a clinically effective dose.
Partner coverage
No missing required partner reduced the findings; this does not establish synergy or added benefit from combining ingredients.
Conflicts
No configured conflict was identified in the supplied facts.
Effective doses
All counted ingredients reach the saved amount threshold; that comparison is not proof of a clinically effective dose.
Impact
Lower effect
Huperzine · 200 mcg
Huperzine Not classified
No linked studies yet.
Impact
Lower effect
Huperzine · 200 mcg
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Huperzine A (Huperzia serrata whole plant extract) | 200 mcg |
Huperzine (Huperzia serrata whole plant extract) · 200 mcg OverallScore79
The serving lists 200 mcg of Huperzine A. The whole-product price works out to about $0.11 per 100 mcg of Huperzine A, which is relatively low.
How this ingredient is rated
Active Ingredient Quality & Bioavailability60
The saved facts identify Huperzia serrata extract, but do not establish its Huperzine A concentration.
Source and Standardization Clarity
A Huperzia serrata extract is identified; its standardization percentage is not established by the available facts.
Dose, Safety & Label Transparency88
The serving lists 200 mcg of Huperzine A. No specific cycling guidance is recorded in the saved facts.
Huperzine A Dosage Efficacy
The serving lists 200 mcg of Huperzine A.
Cycling Guidance and Transparency
The active amount is specified, but no specific cycling guidance is recorded in the saved facts.
Value100
The whole-product price works out to about $0.11 per 100 mcg of Huperzine A, which is relatively low.
Price per 100mcg of Huperzine A
Based on the whole-product price, 100 mcg of Huperzine A costs about $0.11, which is relatively low.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Huperzine a in the treatment of Alzheimer's disease and vascular dementia: a meta-analysis.
- [Clinical efficacy and safety of huperzine Alpha in treatment of mild to moderate Alzheimer disease, a placebo-controlled, double-blind, randomized trial].
- Huperzine A associated with improved early postoperative cognitive function after neurosurgery under general anesthesia: a randomized clinical trial.
- Treatment with Huperzine A improves cognition in vascular dementia patients.
- Huperzine-A response to cognitive impairment and task switching deficits in patients with Alzheimer's disease.
- Adjunctive huperzine A for cognitive deficits in schizophrenia: a systematic review and meta-analysis.
- [Drug evaluation of huperzine A in the treatment of senile memory disorders].
- Effect of Huperzine A on Cognitive Function and Perception of Effort during Exercise: A Randomized Double-Blind Crossover Trial.